Dorman Products, Inc. (DORM) Income Statement

The growth profile has visibly cooled: 2024 through early 2025 consistently printed 3–8% gains, while the trailing three quarters cluster near 1–4%, suggesting the prior uplift from the SuperATV and Dayton Parts acquisitions is annualizing out and organic momentum in the core catalog is softening. Because Dorman's demand is tied to the 6–12 year repair 'sweet spot' of an aging fleet, this deceleration appears inconsistent with record Vehicles-in-Operation tailwinds, which implies shelf-space allocation decisions at the Big Four retailers or SKU rationalization may be constraining sell-through. Management's decision to skip guidance in the Q3 2026 release, as noted in recent context, may indicate limited visibility into whether this ~2% run-rate growth becomes the new baseline.

This degree of gross margin volatility is unusual for a business whose pricing should be anchored by catalog value-add engineering, and it suggests material non-recurring items — plausibly tariff cost recoveries, customer allowance true-ups, or changes in excess-and-obsolete reserves — are distorting underlying profitability rather than structural pricing power shifting. The 46.1% print in 2026Q2 appears difficult to sustain given the immediate reversion to 39.4%, so the normalized margin assumption probably sits closer to the high-30s/low-40s historical average, implying the Q2 'beat' that accompanied the guidance raise deserved more skepticism. Against peers, Dorman's ~40% gross margin still sits well above LKQ's 38.0% and far above MPAA's 20.2%, but that premium is only defensible if it proves stable rather than episodic.

Operating income scaled meaningfully in 2026Q2 ($116.2M, a 21.3% margin) versus 2026Q1 ($58.8M, 11.1%), but that swing was almost entirely gross-margin driven rather than a function of incremental SG&A absorption, so the operating leverage story here looks more like cost-of-goods variance than scalable efficiency. The concerning counterpoint is 2026Q3: revenue rose 3.3% year-over-year while operating income fell to $82.9M from $105.8M in the year-ago quarter, meaning fixed-cost absorption cannot rescue profitability when gross margin contracts. Investors should treat SG&A as a well-managed but largely static line; with R&D reported at zero in every period in this dataset, the data on innovation investment intensity is unavailable rather than reassuring.